F-group (family)
2003.1.5.163 Methyltransf_2, Methyltransf_25
Ligands and drugs
74
Member domains
52
with ligand contacts (≤ 4 Å)
70.3% of members
45
with DrugDomain annotations
60.8% of members
41
with a DrugBank compound
55.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.5.163 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01752 | SAH | S-adenosyl-L-homocysteine | 35 |
| DB19070 | 3VL | Aklavine | 7 |
| DB00118 | SAM | Ademetionine | 5 |
| DB03199 | ERT | 4-Methoxy-E-Rhodomycin T | 4 |
| DB15832 | H9L | Desmeninol | 4 |
| DB07118 | 4MU | Hymecromone | 3 |
| DB01692 | DTU | Dithioerythritol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 39 |
| VAK | methyl (1R,2R,4S)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate | 8 |
| 3VL | methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate | 7 |
| SAM | S-ADENOSYLMETHIONINE | 5 |
| 3DJ | (2S)-2-amino-4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid | 4 |
| ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE | 4 |
| H9L | 4-methylsulfanyl-2-oxidanyl-butanoic acid | 4 |
| 4MU | 7-hydroxy-4-methyl-2H-chromen-2-one | 3 |
| P9P | 2-chloranyl-4-nitro-phenol | 3 |
| A1EI6 | (7S,9R,10R)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethyl-4-methoxy-6,9,10,11-tetrakis(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione | 2 |
| A1L3V | (7~{S},9~{S})-7-[(2~{R},4~{S},5~{S},6~{S})-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethyl-4-methoxy-6,9,11-tris(oxidanyl)-8,10-dihydro-7~{H}-tetracene-5,12-dione | 2 |
| CL | CHLORIDE ION | 2 |
| S8M | (2~{R},3~{R},4~{S},5~{S})-2-(6-aminopurin-9-yl)-5-[[(3~{S})-3-azanyl-3-(1~{H}-1,2,3,4-tetrazol-5-yl)propyl]sulfanylmethyl]oxolane-3,4-diol | 2 |
| DTU | (2R,3S)-1,4-DIMERCAPTOBUTANE-2,3-DIOL | 1 |
| ZBX | methyl (1R,2R,4S)-2-ethyl-7-methoxy-2,4,5-tris(oxidanyl)-6,11-bis(oxidanylidene)-3,4-dihydro-1H-tetracene-1-carboxylate | 1 |